Silence Therapeutics reported $137.15K in Sales Revenues for its fiscal quarter ending in March of 2026.





Sales Change Date
AstraZeneca USD 15.38B 90M Jun/2026
Autolus Therapeutics Ltd USD 45.69M 19.47M Jun/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Novartis USD 14.41B 1.3B Jun/2026
Roche Holding CHF 30.36B 14.71B Jun/2026
Silence Therapeutics USD 137.15K 103.15K Mar/2026